Industry

Improving practice efficiency and patient care with Asana Smiles™ for Align, a workflow with HIPAA compliant features SAN FRANCISCO–(BUSINESS WIRE)–Today Asana, Inc. (NYSE: ASAN)(LTSE: ASAN), a leading work management platform for teams, announced a new strategic partnership with Align Technology, a leading global medical device company that designs, manufactures, and sells the Invisalign system of … [Read more…]

CHICAGO–(BUSINESS WIRE)–Adtalem Global Education (NYSE: ATGE), a leading healthcare educator, has appointed Michael Betz as president, Walden University, effective immediately. In his role, Betz is responsible for the strategy and operations of Walden with a mandate to further enhance Walden’s position as a leading innovator in distance learning while maintaining its commitment to expanding access … [Read more…]

LAS VEGAS–(BUSINESS WIRE)–$NASDAQ #Biotechnology–PharmaCyte Biotech, Inc. (NASDAQ: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, announced today that it has initiated the first in a series of studies to test the ability of its pancreatic cancer therapy to treat malignant ascites. The initiation … [Read more…]

ENHERTU data from historic DESTINY-Breast04 trial in patients with HER2 low metastatic breast cancer has the potential to redefine how breast cancer is categorized and treated First presentation of DS-6000 and new patritumab deruxtecan results further support the strength of Daiichi Sankyo’s DXd ADC technology across multiple cancers including breast, lung, ovarian and renal cell … [Read more…]

A leader in outpatient imaging services to provide smart digital and self-service experiences with NICE CXone to improve services for patients, health systems and hospitals HOBOKEN, N.J.–(BUSINESS WIRE)–#NICE—NICE (Nasdaq: NICE) today announced that MedQuest Associates, a leading manager of outpatient diagnostic imaging facilities, has selected the NICE CXone Essentials Suite to enrich its services to … [Read more…]

ICON kick starts the first half of 2022 with a string of prestigious industry awards recognising healthcare intelligence work and staff, as independently judged by peers worldwide DUBLIN–(BUSINESS WIRE)–ICON plc, (NASDAQ: ICLR) a global provider of drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device, and government organisations, has been recognised with … [Read more…]

– Lead Clinical Candidate, JK07, Demonstrates Favorable Safety and Further Promising Activity in Cohort 2 of Phase 1b Heart Failure with Reduced Ejection Fraction Study; Enrollment in Cohort 3 Now Ongoing – – Clinical Trial Application Submitted in Europe for Lead Oncology Program JK08, the first CTLA-4/IL-15 Antibody Fusion Protein, for the Treatment of Solid … [Read more…]

ENHERTU® (fam-trastuzumab deruxtecan-nxki) data will show the potential to improve survival for metastatic breast cancer patients and define a new segment of HER2-low disease Results from multiple trials further reinforce strength of industry-leading portfolio and pipeline, including novel combinations, across cancers with high unmet need WILMINGTON, Del.–(BUSINESS WIRE)–AstraZeneca advances its ambition to redefine cancer care … [Read more…]

THRIVE-AA1 Study Meets Primary Endpoint for Scalp Hair Regrowth and Key Secondary Endpoints at Both Doses Statistically Significant Hair Regrowth Observed as Early as Eight Weeks CTP-543 Has Potential to be Best-in-Class for the Treatment of Alopecia Areata Topline Data from Second Phase 3 Trial, THRIVE-AA2, Expected Third Quarter of 2022 LEXINGTON, Mass.–(BUSINESS WIRE)–$CNCE #AlopeciaAreata—Concert … [Read more…]

– New Exploratory Findings from 18-Month Analysis of HELIOS-A Suggest that Treatment with Investigational Vutrisiran May Benefit Patients with Hereditary ATTR (hATTR) Amyloidosis and Cardiac Involvement – – Improvements in NT-proBNP and Echocardiographic Parameters Seen in Cardiac Subpopulation – – Reductions in Technetium Uptake Observed in Patients with High Grade Uptake at Baseline – CAMBRIDGE, … [Read more…]